ABL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.246600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.470800E-01
Normal-vs-Stage2
5.565600E-01
Normal-vs-Stage3
1.473820E-01
Normal-vs-Stage4
7.550400E-01
Stage1-vs-Stage2
6.827000E-01
Stage1-vs-Stage3
5.120600E-01
Stage1-vs-Stage4
6.167800E-01
Stage2-vs-Stage3
3.400000E-01
Stage2-vs-Stage4
8.137800E-01
Stage3-vs-Stage4
3.532800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.056400E-01
Normal-vs-AfricanAmerican
7.371400E-01
Normal-vs-Asian
6.463600E-01
Caucasian-vs-AfricanAmerican
6.846800E-01
Caucasian-vs-Asian
9.843600E-01
AfricanAmerican-vs-Asian
7.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.625400E-01
Normal-vs-Female
6.316000E-01
Male-vs-Female
2.227400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.019600E-01
Normal-vs-Age(41-60Yrs)
8.568400E-01
Normal-vs-Age(61-80Yrs)
4.443000E-01
Normal-vs-Age(81-100Yrs)
2.465400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.026600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.886400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.002000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.696500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.137900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.319400E-01
Normal-vs-Daily Drinker
1.772960E-01
Normal-vs-Weekly Drinker
9.188400E-01
Normal-vs-Occasional Drinker
1.249620E-01
Normal-vs-Social Drinker
7.502200E-01
Non Drinker-vs-Daily Drinker
8.964400E-01
Non Drinker-vs-Weekly Drinker
6.402500E-02
Non Drinker-vs-Occasional Drinker
7.680200E-01
Non Drinker-vs-Social Drinker
6.437500E-03
Daily Drinker-vs-Weekly Drinker
6.946200E-02
Daily Drinker-vs-Occasional Drinker
8.529800E-01
Daily Drinker-vs-Social Drinker
6.598400E-03
Weekly Drinker-vs-Occasional Drinker
1.130800E-01
Weekly Drinker-vs-Social Drinker
4.989000E-01
Occasional Drinker-vs-Social Drinker
1.342390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.330800E-01
Normal-vs-Grade 2
2.961000E-01
Normal-vs-Grade 3
7.480200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.742000E-01
Grade 1-vs-Grade 3
8.814600E-01
Grade 1-vs-Grade 4
5.330800E-01
Grade 2-vs-Grade 3
3.069000E-01
Grade 2-vs-Grade 4
2.961000E-01
Grade 3-vs-Grade 4
7.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.345000E-01
Normal-vs-NonDiabetic
4.269400E-01
Diabetic-vs-NonDiabetic
7.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.005200E-01
Normal-vs-NoPancreatitis
4.787000E-01
Pancreatitis-vs-NoPancreatitis
6.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.448200E-01
Normal-vs-N1
5.869400E-01
N0-vs-N1
3.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.802360E-01
Normal-vs-TP53-NonMutant
4.983200E-01
TP53-Mutant-vs-TP53-NonMutant
8.557600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
